当前位置: 首页 > 详情页

Bone marrow mesenchymal stem cells attenuate silica-induced pulmonary fibrosis via paracrine mechanisms

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Sch Publ Hlth, Beijing 100069, Peoples R China; [2]Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing 100069, Peoples R China; [3]Capital Med Univ, Beijing Childrens Hosp, Beijing, Peoples R China; [4]Capital Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Beijing 100069, Peoples R China
出处:
ISSN:

关键词: Bone marrow mesenchymal stem cells Pulmonary fibrosis Silicosis Differentiation Paracrine

摘要:
The purpose of this study was to investigate the anti-fibrotic effect and possible mechanism of bone marrow mesenchymal stem cells (BMSCs) in silica-included lung injury and fibrosis in vivo and in vitro. In vivo, rats were exposed to 50 mg/m1 silica intratracheally. The rats were sacrificed on day 15 or day 30 after intravenous injection of BMSCs. Histopathological examination demonstrated that BMSCs decreased the blue areas of collagen fibers and the number of nodules. Alveolar epithelium was damaged by silica, but it was restored by BMSCs. In vitro, BMSCs co-cultured with RLE-6TN cells in 6Transwell plates were evaluated to determine the possible mechanism. The results demonstrated that BMSCs downregulated the expression of collagen I and III. BMSCs reversed morphological abnormalities and reduced the proliferation of RLE-6TN cells. These data showed that BMSCs did not give rise to alveolar epithelial cells directly, while the levels of hepatocyte growth factor, keratinocyte growth factor and bone morphogenetic protein 7 increased and expression of tumor necrosis factor -alpha and transforming growth factor -beta 1 decreased in the 6TN + Silica + BMSCs group compared with the 6TN + Silica group. Our results revealed that BMSCs exerted anti-fibrotic effects on silica-induced pulmonary fibrosis, which might be associated with paracrine mechanisms rather than differentiation. (C) 2017 Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 2 区 医学
小类 | 2 区 毒理学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 毒理学
JCR分区:
出版当年[2015]版:
Q1 TOXICOLOGY
最新[2023]版:
Q2 TOXICOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Capital Med Univ, Sch Publ Hlth, Beijing 100069, Peoples R China; [2]Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing 100069, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Sch Publ Hlth, Beijing 100069, Peoples R China; [2]Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing 100069, Peoples R China; [4]Capital Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Beijing 100069, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院